Zonagen (zona) - good buy? Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Zonagen (zona) - good buy?

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: drsvelte who wrote (2997)	3/25/1998 10:11:00 AM
From: Craig Markell	Read Replies (1) of 7041

Zonagen Gets Patent For Impotency Drug Vasomax THE WOODLANDS, Texas (Dow Jones)--Zonagen Inc. (ZONA) received a patent for Vasomax, an oral formulation of phentolamine mesylate for treating sexual dysfunction. Zonagen licensed the drug as a treatment for male erectile dysfunction to Schering-Plough Corp. (SGP) in November. In a press release Wednesday, Zonagen said the patent also covers an on-demand treatment for female sexual dysfunction. As reported Tuesday, a group of Zonagen holders filed a suit seeking class-action status against the company, alleging it issued false and misleading statements concerning Vasomax's side effects and efficacy.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next